Advertisement

Most Recent

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

0 Comments

image: Stress Fractures

Stress Fractures

By | January 1, 2015

Social adversity shapes humans’ immune systems—and probably their susceptibility to disease—by altering the expression of large groups of genes.

6 Comments

image: The Year in Pathogens

The Year in Pathogens

By | December 29, 2014

Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research

0 Comments

image: Reprogramming Redux

Reprogramming Redux

By | December 18, 2014

Can mechanical forces alone be manipulated to create stem-like cells?

1 Comment

image: Ebola Update

Ebola Update

By | December 17, 2014

Plasma-based therapy trials begin in West Africa; NIH-GSK vaccine shows promise in Phase 1; the real statistics

0 Comments

image: Ebola Update

Ebola Update

By | December 11, 2014

NIH admits new patient; joint pains stall clinical trial; U.S. grants immunity to vaccine developers; more

1 Comment

image: Honeybee Compound for Hair Loss?

Honeybee Compound for Hair Loss?

By | December 11, 2014

Propolis, a natural product used by honeybees to repair their hives, stimulates hair growth in shaved mice.

1 Comment

image: New NIH IRB Guidelines Proposed

New NIH IRB Guidelines Proposed

By | December 8, 2014

A draft policy from the US National Institutes of Health suggests that clinical studies performed at multiple sites should be reviewed by a single institutional review board.

0 Comments

image: Enzyme Design

Enzyme Design

By | December 3, 2014

Researchers create synthetic enzymes in the lab, encoded by artificial genetic material.

1 Comment

image: Ebola Vaccine Candidate Shows Promise

Ebola Vaccine Candidate Shows Promise

By | December 1, 2014

An experimental Ebola vaccine developed by the US National Institutes of Health appears to be safe and effective, according to a small, early-stage clinical trial.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Diagenode Inc
Diagenode Inc
Advertisement